Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
70.02
-9.84 (-12.32%)
At close: Jan 23, 2026, 4:00 PM EST
69.62
-0.40 (-0.57%)
After-hours: Jan 23, 2026, 7:47 PM EST
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $4.73 billion as of January 23, 2026. Its market cap has increased by 71.97% in one year.
Market Cap
4.73B
Enterprise Value
4.15B
1-Year Change
71.97%
Ranking
Category
Stock Price
$70.02
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $4.73B, an increase of 484.20%. That is a compound annual growth rate of 100.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 5.39B | 5.80% |
| Dec 31, 2025 | 5.09B | 97.62% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
| Jul 14, 2023 | 808.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PTC Therapeutics | 6.14B |
| Cogent Biosciences | 6.08B |
| Belite Bio | 5.99B |
| Kymera Therapeutics | 5.75B |
| Crinetics Pharmaceuticals | 5.70B |
| CRISPR Therapeutics AG | 5.64B |
| Immunovant | 5.30B |
| Protagonist Therapeutics | 5.29B |